Page 210 - 2021_09-Haematologica-web

Letters to the Editor
References
1. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223):497-506.
2. Abrams ST, Su D, Sahraoui Y, et al. Assembly of alternative pro- thrombinase by extracellular histones initiates and disseminates intravascular coagulation. Blood. 2021;137(1):103-114.
3.Cheng Z, Abrams ST, Alhamdi Y, et al. Circulating histones are major mediators of multiple organ dysfunction syndrome in acute critical illnesses. Crit Care Med. 2019;47(8):e677-e684.
4. WHO Coronavirus Disease (COVID-19) Dashboard. 2020 [cited 18th September 2020]; Available from: https://covid19.who.int/
5. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortal- ity of adult inpatients with COVID-19 in Wuhan, China: a retro- spective cohort study. Lancet. 2020;395(10229):1054-1062.
6. Wichmann D, Sperhake JP, Lütgehetmann M, et al. Autopsy find- ings and venous thromboembolism in patients with COVID-19. Ann Intern Med. 2020;173(4):268-277.
7. Alhamdi Y, Abrams ST, Lane S, Wang G, Toh CH. Histone-associat- ed thrombocytopenia in patients who are critically ill. JAMA. 2016;315(8):817-819.
8. Abrams ST, Zhang N, Manson J, et al. Circulating histones are medi-
ators of trauma-associated lung injury. Am J Respir Crit Care Med.
2013;187(2):160-169.
9. Abrams ST, Zhang N, Dart C, et al. Human CRP Defends against
the toxicity of circulating histones. J Immunol. 2013;191(5):2495-
2502.
10. Xu J, Zhang X, Pelayo R, et al. Extracellular histones are major medi-
ators of death in sepsis. Nat Med. 2009;15(11):1318-1321.
11. Docherty AB, Harrison EM, Green CA, et al. Features of 20,133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study.
BMJ. 2020;369:m1985.
12.Alhamdi Y, Abrams ST, Cheng Z, et al. Circulating histones are
major mediators of cardiac injury in patients with sepsis. Crit Care
Med. 2015;43(10):2094-2103.
13. Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are
associated with poor prognosis in patients with novel coronavirus
pneumonia. J Thromb Haemost. 2020;18(4):844-847.
14. Klok FA, Kruip MJHA, van der Meer NJM, et al. Incidence of throm- botic complications in critically ill ICU patients with COVID-19.
Thromb Res. 2020;191:145-147.
15. Middleton EA, He XY, Denorme F, et al. Neutrophil extracellular
traps contribute to immunothrombosis in COVID-19 acute respira- tory distress syndrome. Blood. 2020;136(10):1169-1179.
2498
haematologica | 2021; 106(9)